Cyprus Mail on MSN
Sequoia zanubrutinib study: Long-term insights into BTK inhibition in treatment-naïve CLL/SLL
IntroductionBruton’s tyrosine kinase (BTK) is at the core of present day treatment in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) which in turn is redefining first line and ...
An ADC with a novel RNA spliceosome modulating payload PH1 paired with a KRAS inhibitor demonstrates synergistic cytotoxic ...
Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated ...
Nuri Jeong remembers the feeling of surprise she felt during a trip back to South Korea, while visiting her grandmother, who'd been grappling with Alzheimer's disease. "I hadn't seen her in six years, ...
A new study has revealed that neural inhibition and balanced neural activity in a specific area of the brain is required for recognition memory. The findings could help provide better understanding of ...
In the split second that is needed to view a stop sign and react to it, our brain navigates a complex process that transitions seamlessly from perception to action control. This ability to halt or ...
MKIs uniquely block multiple receptor tyrosine kinases (RTKs) simultaneously, addressing the inflammatory, vascular, and ...
Researchers have successfully engineered an L-amino acid deaminase to overcome substrate inhibition, a major bottleneck in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results